Skip to main content

Table 9 Emergence from anesthesia

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

  Remifentanil (n = 47) Dexmedetomidine (n = 47) P
Patients with delayed emergence 2 (4.26) 6 (12.77) 0.267
Time to emergence (min)* 14 (11, 18) 15 (10, 24) 0.066
Time to extubation (min)* 19 (15, 25) 19 (15, 29) 0.051
Patients with SAS ≥ 5 at extubation 2 (4.26) 6 (12.77) 0.267
Patients with SAS ≥ 5 at 1 min after extubation 0 (0.00) 2 (4.26) 0.495
Patients with SAS ≥ 5 at 5 min after extubation 0 (0.00) 1 (2.13) 1.000
  1. Values expressed as numbers and percentages, or medians and interquartile ranges (25th percentile, 75th percentile)
  2. SAS Sedation-Agitation scale
  3. *Mann–Whitney U-test